The European Commission published a draft revision of the European Good Manufacturing Practice (GMP), Annex 1, on Manufacturing of Sterile Medicinal Products which will include specific guidance on the use and risk control of single-use systems. Here, it is emphasized that the use of closed systems such as single-use systems can reduce the risk of cross-contamination.
During this webinar, we will focus on points to consider assuring sterility and integrity of a single-use assembly, and how collaboration between supplier and end-user can support the overall contamination control strategy of final filtration and filling operation.
In this webinar, you will learn:
Simone Biel, Ph.D.
Senior Regulatory Consultant
Simone Biel provides regulatory and scientific expertise to our customers and internal stakeholders globally with a focus on single-use technology. Over the years, Simone has supported biopharmaceutical drug manufacturers’ implementation of single-use technology in their manufacturing process. With her deep understanding of single-use technology market needs and industry trends, she is the subject matter expert to ensure that product performance meets quality and regulatory requirements. Simone holds a Ph.D. from the University of Frankfurt in microbiology.
Somasundaram G (Som)
Som is a consultant with customers for regulatory compliance, closed processing, and other areas in biopharmaceutical applications. He is also a member of PDA and ISPE industry associations. Som has worked in different functions within MilliporeSigma for the last 19 years, including heading technology management, tech service, BioReliance® filter validation lab, commercial role, and business development areas. He also worked for a year in QA/QC as well as obtained one year of academic experience in microbiology.
To continue reading please sign in or create an account.Don't Have An Account?